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INTRODUCTION {#ped412035-sec-0006}
============

POR deficiency manifests with a wide range of clinical signs and symptoms. Mild cases can include primary amenorrhea, infertility in both men and women, and polycystic ovarian syndrome (PCOS). People with moderate cases of PORD may have ambiguous genitalia, and they usually do not have skeletal abnormalities. The severe form of PORD is sometimes called Antley‐Bixler syndrome (ABS) with genital anomalies and disordered steroidogenesis. Hormonal changes in affected males and females lead to the development of ambiguous genitalia or other genital abnormalities, as well as infertility. Severe cases are also characterized by midface hypoplasia, choanal stenosis or atresia, and multiple joint contractures.[1](#ped412035-bib-0001){ref-type="ref"}

Exclusively skeletal form of ABS without genital anomalies or disordered steroidogenesis can be caused by heterozygous mutation in the gene encoding for fibroblast growth factor receptor 2 (FGFR2).[2](#ped412035-bib-0002){ref-type="ref"}, [3](#ped412035-bib-0003){ref-type="ref"}

However, mutations in cytochrome P450 oxidoreductase (POR) were identified as the cause of ABS with genital anomalies and disordered steroidogenesis.[4](#ped412035-bib-0004){ref-type="ref"}, [5](#ped412035-bib-0005){ref-type="ref"} These mutations affect steroidogenesis by disrupting the ability of *POR* to transfer electrons from nicotinamide adenine dinucleotide phosphate (NADPH) to 17α‐hydroxylase/17,20‐lyase (P450c17), steroid aromatase (P450aro) and 21‐hydroxylase (P450c21), resulting in deficiency of P450c17, P450aro and P450c21.[5](#ped412035-bib-0005){ref-type="ref"}, [6](#ped412035-bib-0006){ref-type="ref"}

Here, we report a 1‐year‐old Chinese male patient who first manifested head, skeletal and genitalia anomalies. He was misdiagnosed with Crouzon syndrome due to craniosynostosis and frontal bossing. We performed whole‐exome sequencing (WES) on the patient and his unaffected parents, and found unreported compound heterozygous mutations in *POR* in the proband.

METHODS {#ped412035-sec-0007}
=======

Clinical examination and testing {#ped412035-sec-0008}
--------------------------------

Informed consents were obtained and clinical examinations were performed. The proband underwent detailed physical evaluations by an experienced pediatrician, including radiographs of limbs, chest and spine, endoscope for ENT (ear, nose and throat), computerized tomography (CT) of accessory nasal sinuses, magnetic resonance imaging (MRI) of the skull, and other necessary tests. Karyotyping were the preliminary examinations conducted. At 2 months and 10 months of age, serum samples were sent for steroid analysis.

Whole‐exome sequencing {#ped412035-sec-0009}
----------------------

DNA was isolated from 200 μL blood samples from the proband and his parents. Exon capture was performed using the Agilent SureSelect Human All Exome V6 kit (Agilent Technologies Inc. Mississauga, ON, Canada). Whole‐exome sequencing was performed on an Illumina Hiseq X Analyzers (Illumina, San Diego, CA, USA) using standard protocols for 150‐bp paired‐end runs.

Analysis and evaluation of variants {#ped412035-sec-0010}
-----------------------------------

The sequences obtained were aligned to the GRCh37/hg19 human reference genome. Variant frequency was analyzed using three SNP databases (db‐SNP147, gnomAD and 1000 Genomes Project Database) and three disease databases (ClinVar, OMIM, and HGMD). We filtered all common variants with MAF ≥0.005. In order to identify the potential impact of the identified mutations on protein function, we used five applications: SIFT (<http://sift.jcvi.org/www/SIFT_enst_submit.html>), Polyphen‐2 (<http://genetics.bwh.harvard.edu/pph2/>), MutationTaster (<http://www.mutationtaster.org>), Mutation Assessor (<http://mutationassessor.org/>) and CADD (<http://cadd.gs.washington.edu/>). Loss‐of‐function (LoF) mutations, such as nonsense/splicing mutations and frameshift indels, were considered to be deleterious.

Sanger sequencing {#ped412035-sec-0011}
-----------------

The variants detected by whole‐exome sequencing were verified through Sanger sequencing. Primers for PCR and Sanger sequencing were designed to cover mutated bases and flanking sequence. DNA samples from the proband and his parents were amplified. Direct sequencing was performed using the BigDye^™^ Terminator Cycle Sequencing kit and analyzed on a 3730xl automated sequencer (Applied Biosystems, Foster City, CA, USA).

RESULTS {#ped412035-sec-0012}
=======

Clinical findings {#ped412035-sec-0013}
-----------------

A newborn boy was first evaluated in the neonatal intensive care unit because of congenital dysplasia. He was born at 38 weeks gestation via Cesarean because of oligohydramnios for a week. Apgars were 10 at 1 min. Birth weight was 2.9 kg. On examination, the baby was dysmorphic with frontal bossing, bilateral proptosis, hypertelorism, depressed nasal bridge, micropenis and right cryptorchidism (Table [1](#ped412035-tbl-0001){ref-type="table"}). Mouth breathing and triretraction sign were observed in this baby indicating choanal or airway stenosis. Extremities had bilateral decreased extension and supination of the elbows and clinodactyly of the fourth toe. Bilateral lower extremities were hypotonic. The phallic stretched length was 1.5 centimeter (\<−2.5 SD in Chinese). Testicular volume was 1 mL. There was no family history of these disorders. The mother was a 35‐year‐old primigravida with Hashimoto\'s thyroiditis for eight years. The mother developed some signs of virlization during her pregnancy such as hirsutism and acne.

###### 

Phenotypes of the proband fitting the diagnostic criteria of PORD

  Head                            Skeletal                  Genitalia
  ------------------------------- ------------------------- ----------------------
  frontal bossing                 craniosynostosis          micropenis
  bilateral proptosis             radiohumeral synostosis   right cryptorchidism
  hypertelorism                   radioulnar synostosis     
  depressed nasal bridge          chest wall deformity      
  low‐set ears choanal stenosis                             
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The radiographs of upper limbs displayed fusion of certain adjacent bones of the arms, including bilateral radiohumeral synostosis (Figure [2](#ped412035-fig-0002){ref-type="fig"}A). The radiographs of chest and spine displayed scoliosis (Figure [2](#ped412035-fig-0002){ref-type="fig"}B). Endoscope for ENT (Figure [1](#ped412035-fig-0003){ref-type="fig"}) and CT of accessory nasal sinuses at 3 months of age confirmed a bony or thin layer of tissue blocking the passageway between the nose and throat, leading to difficulties in breathing. MRI of the skull at 10 months of age revealed brachycephaly with a flat occiput, frontal bossing, and broad forehead, suggesting craniosynostosis (Figure [3](#ped412035-fig-0001){ref-type="fig"}B).

![Endoscope for ENT showed choanal stenosis.](PED4-2-90-g003){#ped412035-fig-0003}

![Skeletal abnormalities of arms and chest. A, The radiographs of arms showed bilateral radiohumeral synostosis. B, The radiographs of chest and spine showed scoliosis.](PED4-2-90-g002){#ped412035-fig-0002}

![Skeletal abnormalities of head a nd face. A, Facial characteristics at age of 8 months. B, MRI of the skull revealed premature fusion of the skull bones (craniosynostosis), a flattened mid‐face, frontal bossing, broad forehead and low‐set ears.](PED4-2-90-g001){#ped412035-fig-0001}

Laboratory abnormalities {#ped412035-sec-0014}
------------------------

The results of laboratory examinations were shown in Table [2](#ped412035-tbl-0002){ref-type="table"}. At 2 months of age, baseline cortisol (COR) was normal, at 15.40 μg/dL (normal range 5--25 μg/dL), and adrenocorticotropic hormone (ACTH) was elevated, at 253.0 pg/mL (normal range 0--46 pg/mL). At 10 months of age, the patient had high levels of ACTH (116.6 pg/mL) and progesterone (PGN) (13.30 ng/mL; normal ≤2 ng/mL), with normal values for baseline COR, luteinizing hormone (LH), follicle‐stimulating hormone (FSH), testosterone (T) and prolactin (PRL).

###### 

Laboratory tests of the proband

                     2 months   10 months   Reference ranges
  ------------------ ---------- ----------- ------------------
  ACTH 8AM (pg/mL)   253.00     116.60      0--46
  COR 8AM (μg/dL)    15.40      7.33        5--25
  T (ng/dL)          ‐          58.90       0--106.90
  PGN (ng/mL)        ‐          13.30       ≤2
  LH (IU/L)          ‐          1.47        ≤4.10
  FSH (IU/L)         ‐          1.27        ≤5.50
  PRL (ng/mL)        ‐          24.30       0.60--29.00

ACTH: adrenocorticotropic; COR: cortisol; T: testosterone; PGN: progesterone; LH: luteinizing hormone; FSH: follicle‐stimulating hormone; PRL: prolactin.
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Pathogenicity of two *POR* variants {#ped412035-sec-0015}
-----------------------------------

Karyotyping showed a normal male 46, XY. The mean coverage of WES was 98.4% and the average sequencing depth of the exomes was above 100×. A heterozygous nonsense variant c.667C\>T (p.R223\*) and a heterozygous missense variant c.1370G\>A (p.R457H) in *POR* were identified in the patient (Table [3](#ped412035-tbl-0003){ref-type="table"}), which was inherited from his father and mother, respectively. The two variants of *POR* were confirmed by Sanger sequencing in the proband and his parents (Figure [4](#ped412035-fig-0004){ref-type="fig"}). They were also evaluated using five *in silico* predictive algorithms (Table [4](#ped412035-tbl-0004){ref-type="table"}) and most of them showed pathogenic prediction.

###### 

Two genetic variants of *POR* in the proband

  Gene    Transcript    cDNA         Protein Heterozygosity   Co‐segregation                        gnomAD East Asian   1000 Genomes   dbSNP number
  ------- ------------- ------------ ------------------------ ------------------------------------- ------------------- -------------- --------------
  *POR*   NM_000941.2   c.667C\>T    p.R223\*                 Heterozygous Proband and his father   0                   ‐              rs782677940
  *POR*   NM_000941.2   c.1370G\>A   p.R457H                  Heterozygous Proband and his mother   0.0004688           0.0002         rs28931608
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![Sanger sequencing analysis of *POR* in the patient and his parents. The arrows indicated the mutated nucleotides. The patient carries a compound heterozygous nonsense mutation (p.R223\*) and a missense mutation (p.R457H) in *POR*. p.R223\* was inherited from patient\'s heterozygous father and p.R457H was inherited from patient\'s heterozygous mother.](PED4-2-90-g004){#ped412035-fig-0004}

###### 

Predicted pathogenicity of the two genetic variants of *POR*

  Gene    cDNA, Protein         SIFT       Polyphen‐2          Mutation Taster   Mutation Assessor   CADD
  ------- --------------------- ---------- ------------------- ----------------- ------------------- ------
  *POR*   c.667C\>T, p.R223\*   ‐          ‐                   Disease‐causing   ‐                   ‐
  *POR*   c.1370G\>A, p.R457H   Damaging   Probably damaging   Disease‐causing   High impact         32
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The nonsense mutation (c.667C\>T, p.R223\*) in exon 6 were inherited from the proband\'s father, which creates a premature stop codon at codon 223. The *in silico* predictive algorithms on the MutationTaster server predicted it to be pathogenic. The missense mutation (c.1370G\>A, p.R457H) in exon 11 is a single‐nucleotide polymorphism (SNP) in dbSNP150 (rs28931608), which was inherited from the proband\'s mother. The allele frequency (AF) among East Asian people is as low as 0.0004688 (8/17 066) according to gnomAD (Table [3](#ped412035-tbl-0003){ref-type="table"}). Multiple lines of computational evidence (SIFT, PolyPhen‐2, MutationTaster, Mutation Assessor and CADD) supported a deleterious effect of this variant on the gene or gene product (Table [4](#ped412035-tbl-0004){ref-type="table"}).

DISCUSSION {#ped412035-sec-0016}
==========

The patient was suspected of having Crouzon syndrome due to craniosynostosis and frontal bossing and came to our hospital for a genetic test. Crouzon syndrome is an autosomal dominant disorder is an autosomal dominant disorder caused by *FGFR2* mutations.[7](#ped412035-bib-0007){ref-type="ref"}, [8](#ped412035-bib-0008){ref-type="ref"} However, using whole‐exome sequencing, we found a compound heterozygous nonsense mutation (p.R223\*) and a missense mutation (p.R457H) in *POR* in the proband. This mutation inherited from healthy heterozygous parents and is an unreported compound heterozygous mutation in *POR*.

The *POR* gene encodes a flavoprotein that transfers electrons from NADPH to all microsomal cytochrome P450 type II (including 21‐hydroxylase, 17α‐hydroxylase/17, 20‐lyase and aromatase), which is fundamental for their enzymatic activity.[5](#ped412035-bib-0005){ref-type="ref"} *POR* mutations cause variable impairments in steroidogenic enzyme activities that result in wide phenotypic variability ranging from mild to severe. Signs and symptoms of mild‐to‐moderate PORD include primary amenorrhea, polycystic ovarian syndrome (PCOS), infertility in both men and women, and ambiguous genitalia. The severe form of *POR* mutations is called Antley‐Bixler syndrome with genital anomalies and disordered steroidogenesis. The main anomalies of PORD are characterized by craniofacial, skeletal, extremity and urogenital anomalies. Recently, a female Chinese patient with a homozygous missense mutation (p.R457H) was described, who presented with amenorrhea and recurrence of large ovary cyst but had not a typical skeletal deformity.[6](#ped412035-bib-0006){ref-type="ref"}

Our patient presented severe craniofacial, skeletal, extremity malformation with frontal bossing, depressed nasal bridge, craniosynostosis, radiohumeral synostosis, scoliosis and camptodactyly in feet. Urogenital anomalies were also observed as micropenis and right cryptorchidism. In addition, *POR* mutations can lead to an apparent combined 17‐hydroxylase/21‐hydroxylase deficiency.

The p.R457H mutation is the most frequent mutation in Japanese PORD patients, and it is observed in approximately 65.4% of unrelated alleles.[9](#ped412035-bib-0009){ref-type="ref"} Other ethnic groups also have the R457H mutation.[5](#ped412035-bib-0005){ref-type="ref"} This mutation destroyed *Bsa* XI and *Tst*I sites, but these enzymes recognize degenerate 33--37 base sequences and cut both strands twice.[5](#ped412035-bib-0005){ref-type="ref"} Two PORD cases have been reported as compound heterozygous carriers including p.R223\* in *POR* [10](#ped412035-bib-0010){ref-type="ref"}, [11](#ped412035-bib-0011){ref-type="ref"} and was predicted to induce a large splicing change.[12](#ped412035-bib-0012){ref-type="ref"}

Antley‐Bixler syndrome (ABS) is a variant of the autosomal dominant group of craniosynostosis syndromes caused by mutant FGF receptors, usually *FGFR2* gene. PORD, sometimes called ABS with disordered steroidogenesis, is an autosomal recessive disorder caused by mutations in *POR*.[3](#ped412035-bib-0003){ref-type="ref"}, [5](#ped412035-bib-0005){ref-type="ref"} It is clinically important to distinguish patients with PORD from those with ABS, because patients with *POR* deficiency are vulnerable to different risk factors and require different management and different teams of physicians.[5](#ped412035-bib-0005){ref-type="ref"} In this case, ABS could also be suspected, based on the head and skeletal anomaly. However, the anomaly of genitalia could be a target for the differentiation between ABS and PORD, which demonstrated the clinical value of physical examination of genitalia. *POR* plays an important role in biological activities such as biosynthesis, cholesterol metabolism, sex hormone metabolism and the metabolism of drugs and toxins.[6](#ped412035-bib-0006){ref-type="ref"} Patients with *POR* mutations may require steroid hormone supplementation and may be at risk for adrenal insufficiency and Addisonian crisis, especially at severe febrile illness or major surgery.[3](#ped412035-bib-0003){ref-type="ref"} The mutation of *POR* gene or associated SNPs may affect drug metabolism in human body.[13](#ped412035-bib-0013){ref-type="ref"}, [14](#ped412035-bib-0014){ref-type="ref"} For example, the R457H mutation in this patient can inactivate the P450 enzymes including CYP1A2, CYP2C19, CYP2D6 and CYP3A4, which are important for drug metabolism.[15](#ped412035-bib-0015){ref-type="ref"}, [16](#ped412035-bib-0016){ref-type="ref"} Thus, there may be possible risks if the patients with R457H mutations are treated with medications metabolized by these enzymes.

CONCLUSIONS {#ped412035-sec-0017}
===========

We have identified a pathogenic variant with an unreported compound heterozygous *POR* mutation. This case report expands the clinical and genetic spectra of PORD and emphasizes the usefulness of WES for genetic diagnosis.
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